A5101710382- Bladder and Urothelial Cancer Treatments
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
- Cancer-related molecular mechanisms research
- Renal and Vascular Pathologies
- Intestinal Malrotation and Obstruction Disorders
- RNA modifications and cancer
- Intracranial Aneurysms: Treatment and Complications
- Cancer, Lipids, and Metabolism
Shandong Provincial Hospital
2019-2021
Shandong First Medical University
2021
Shandong University
2019-2020
Liquid biopsy is becoming a promising method for non-invasive cancer detection. In several proof-of-concept studies, long non-coding RNAs (lncRNAs) were found to be potential biomarkers bladder The objective of this study was discover panel cell-free, urinary lncRNAs as liquid non-invasively differentiate from chronic urocystitis. To end, we collected urine samples both patients and urocystitis patients. These divided into discovery group validation group. the group, expression levels 16...
Objective . This study is aimed at using genes related to the peroxisome proliferator-activated receptor (PPAR) pathway establish a prognostic risk model in kidney renal clear cell carcinoma (KIRC). Methods For this study, we first found PPAR pathway-related on gene set enrichment analysis (GSEA) website and KIRC mRNA expression data clinical through TCGA database. Subsequently, used R language multiple expansion packages analyze expression, hazard ratio analysis, coexpression of KIRC....
Ribophorin II (RPN2) is a highly conserved glycoprotein involved in the N-linked glycosylation of multiple proteins. RPN2 was reported to be associated with malignant phenotype several tumors. However, function bladder cancer (BCa) remains unclear.Expression BCa and adjacent tissues compared by bioinformatics analysis, immunohistochemistry, Western blotting. qRT-PCR performed explore correlation between expression various clinical features 38 patients. We assessed effects on biological...